1. Home
  2. CPIX vs JMM Comparison

CPIX vs JMM Comparison

Compare CPIX & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • JMM
  • Stock Information
  • Founded
  • CPIX 1999
  • JMM 1988
  • Country
  • CPIX United States
  • JMM United States
  • Employees
  • CPIX N/A
  • JMM N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • JMM Trusts Except Educational Religious and Charitable
  • Sector
  • CPIX Health Care
  • JMM Finance
  • Exchange
  • CPIX Nasdaq
  • JMM Nasdaq
  • Market Cap
  • CPIX 68.7M
  • JMM 58.2M
  • IPO Year
  • CPIX 2009
  • JMM N/A
  • Fundamental
  • Price
  • CPIX $4.36
  • JMM $6.20
  • Analyst Decision
  • CPIX
  • JMM
  • Analyst Count
  • CPIX 0
  • JMM 0
  • Target Price
  • CPIX N/A
  • JMM N/A
  • AVG Volume (30 Days)
  • CPIX 112.7K
  • JMM 16.1K
  • Earning Date
  • CPIX 03-04-2025
  • JMM 01-01-0001
  • Dividend Yield
  • CPIX N/A
  • JMM 5.44%
  • EPS Growth
  • CPIX N/A
  • JMM N/A
  • EPS
  • CPIX N/A
  • JMM N/A
  • Revenue
  • CPIX $37,867,945.00
  • JMM N/A
  • Revenue This Year
  • CPIX N/A
  • JMM N/A
  • Revenue Next Year
  • CPIX N/A
  • JMM N/A
  • P/E Ratio
  • CPIX N/A
  • JMM N/A
  • Revenue Growth
  • CPIX N/A
  • JMM N/A
  • 52 Week Low
  • CPIX $1.04
  • JMM $5.29
  • 52 Week High
  • CPIX $7.25
  • JMM $6.10
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 44.29
  • JMM 50.95
  • Support Level
  • CPIX $3.91
  • JMM $6.15
  • Resistance Level
  • CPIX $4.47
  • JMM $6.45
  • Average True Range (ATR)
  • CPIX 0.34
  • JMM 0.07
  • MACD
  • CPIX -0.15
  • JMM 0.00
  • Stochastic Oscillator
  • CPIX 26.63
  • JMM 32.43

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

Share on Social Networks: